Should oligomonocytic CMML be classified as an independent disease entity?
Helong Gary Zhao
Abstract:The 2022 WHO Classification revised the diagnostic criteria of CMML and included the variant, formerly known as oligomonocytic CMML (O‐CMML), into the CMML disease. CMML is currently subtyped into MD‐CMML and MP‐CMML. In a recent study, Castaño‐Díez et al. showed that the newly included O‐CMML has unique clinical features and is an independent favourable risk factor, and proposed to view O‐CMML as an independent subtype of CMML, parallel to MD‐CMML and MP‐CMML.Commentary on: Castaño‐Díez et al. Characteristics… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.